Literature DB >> 9279992

The evaluation of the 29 and 31 kDa antigens in female Angiostrongylus cantonensis for serodiagnosis of human angiostrongyliasis.

S Nuamtanong1.   

Abstract

The objective of this study was to evaluate the crude somatic extract of female Angiostrongylus cantonensis by ELISA and to evaluate the 29 kDa and the 31 kDa components of female worm by EITB for serodiagnosis of human angiostrongyliasis. Using ELISA, cross reaction occurred among all sera tested except capillariasis. The sensitivity, specificity, positive and negative predictive values of ELISA were found to be 100%, 66.8%, 27.1% and 100% respectively. Using EITB, The 29 kDa component cross-reacted with most of the heterologous sera while the 31 kDa component was recognized by 69.2% (18/26) sera from angiostrongyliasis patients, cross-reacted only with trichinellosis, trichuriasis and opisthorchiasis sera. This component may possibly used as reliable agents for angiostrongyliasis out of other tissue infected helminthiasis. The sensitivity, specificity, positive and negative predictive values of EITB for the 31.0 kDa component were 69.2%, 82.4%, 46.2% and 92.5% respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9279992

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  20 in total

1.  Differences of larval development and pathological changes in permissive and nonpermissive rodent hosts for Angiostrongylus cantonensis infection.

Authors:  Lisi OuYang; Jie Wei; Zhongdao Wu; Xin Zeng; Youlan Li; Yu Jia; Yuxin Ma; Mali Zhan; Wanlong Lei
Journal:  Parasitol Res       Date:  2012-07-10       Impact factor: 2.289

Review 2.  Human Angiostrongylus cantonensis: an update.

Authors:  Q-P Wang; Z-D Wu; J Wei; R L Owen; Z-R Lun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-05       Impact factor: 3.267

3.  First Evidence of Angiostrongyliasis Caused by Angiostrongylus cantonensis in Guadeloupe, Lesser Antilles.

Authors:  Céline Dard; Jean-Eudes Piloquet; Yvonne Qvarnstrom; LeAnne M Fox; Helmi M'kada; Jean-Christophe Hebert; Didier Mattera; Dorothée Harrois
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

4.  Cloning and expression of a 16-kDa recombinant protein from Angiostrongylus cantonensis for use in immunoblot diagnosis of human angiostrongyliasis.

Authors:  Apichat Vitta; Paron Dekumyoy; Chalit Komalamisra; Thareerat Kalambaheti; Timothy P Yoshino
Journal:  Parasitol Res       Date:  2016-07-13       Impact factor: 2.289

Review 5.  Central nervous system manifestations of Angiostrongylus cantonensis infection.

Authors:  Yuri C Martins; Herbert B Tanowitz; Kevin R Kazacos
Journal:  Acta Trop       Date:  2014-10-13       Impact factor: 3.112

6.  The current status of laboratory diagnosis of Angiostrongylus cantonensis infections in humans using serologic and molecular methods.

Authors:  Patricia P Wilkins; Yvonne Qvarnstrom; A Christian Whelen; Caitlin Saucier; Alexandre J da Silva; Praphathip Eamsobhana
Journal:  Hawaii J Med Public Health       Date:  2013-06

Review 7.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

8.  Development and evaluation of a Western blot kit for diagnosis of human trichinellosis.

Authors:  Hélène Yera; Shakir Andiva; Catherine Perret; Denis Limonne; Pascal Boireau; Jean Dupouy-Camet
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

9.  Identification of stage-specific proteins of Angiostrongylus vasorum (Baillet, 1866) Kamensky.

Authors:  Viviane De Oliveira Vasconcelos; Ricardo Wagner De Almeida Vitor; Walter Dos Santos Lima
Journal:  Parasitol Res       Date:  2007-12-01       Impact factor: 2.289

10.  Preliminary molecular characterization of the human pathogen Angiostrongylus cantonensis.

Authors:  Hualiang He; Mei Cheng; Xiao Yang; Jinxiu Meng; Ai He; Xiaoying Zheng; Zhuoya Li; Pengjuan Guo; Zhihua Pan; Ximei Zhan
Journal:  BMC Mol Biol       Date:  2009-10-25       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.